12:00 AM
Jun 18, 2012
 |  BC Week In Review  |  Company News  |  Deals

Hisamitsu, Sanofi deal

Sanofi and Hisamitsu will form a 51/49 JV to market OTC allergy medications in Japan. The JV, which...

Read the full 69 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >